论文部分内容阅读
目的:研究康赛迪配合放化疗治疗宫颈癌的增敏解毒作用。方法:将51例宫颈癌患者随机分成观察组和对照组,观察组根治性放疗加同步化疗开始即同时口服康赛迪胶囊。对照组常规放疗加同步化疗。结果:观察组和对照组控制瘤体的完全缓解率分别为92.5%和80%,治疗后白细胞减少发生率25%和48%,差异有统计学意义(P<0.05)。结论:康赛迪配合放化疗治疗宫颈癌能提高近期疗效及改善生活质量,并有效减轻放化疗的不良反应,具有良好的协调作用。
OBJECTIVE: To study the sensitization and detoxification effects of Kandide combined with chemoradiotherapy in the treatment of cervical cancer. Methods: 51 cases of cervical cancer patients were randomly divided into observation group and control group, the observation group of radical radiotherapy plus simultaneous chemotherapy began at the same time, Kangsidi capsules. Control group conventional radiotherapy plus synchronous chemotherapy. Results: The complete remission rate was 92.5% and 80% respectively in control group and control group. The incidence of leukopenia after treatment was 25% and 48%, respectively. The difference was statistically significant (P <0.05). Conclusions: Consolidated radiotherapy and chemotherapy for cervical cancer can improve the short-term curative effect and improve the quality of life, and effectively reduce the side effects of radiotherapy and chemotherapy, which has a good coordination effect.